BML-210
BML-210 (CAY10433) is a novel histone deacetylase (HDAC) inhibitor. It is utilized in biochemical and cancer research to study epigenetic regulation, demonstrating activity in both cellular assays and animal models of disease.
Product Specifications
CAS Number
537034-17-6
Product Name Alternative
Inhibit, Inhibitor, Histone deacetylases, HDAC, CAY10433, CAY-10433, CAY 10433, BML210, BML-210, BML 210, Apoptosis
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
>98%
Bioactivity
HDAC inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 10 mg/ml with warming)
Smiles
Nc1ccccc1NC (=O) CCCCCCC (=O) Nc1ccccc1
Molecular Formula
C20H25N3O2
Molecular Weight
339.44
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N1- (2-Aminophenyl) -N8-phenyloctanediamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb504441 100 µL
Phospho-BLNK (Tyr84) Rabbit Polyclonal Antibody (HRP)
Sign In for Pricing
View Details